1. Home
  2. Labeler Index
  3. Glaxosmithkline Llc
  4. 0173-0869
  5. NDC Package Code: 0173-0869-06 Anoro Ellipta

NDC Package 0173-0869-06 Anoro Ellipta

Umeclidinium Bromide And Vilanterol Trifenatate Powder Respiratory (inhalation) - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0173-0869-06
Package Description:
1 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 7 POWDER in 1 INHALER
Product Code:
0173-0869
Proprietary Name:
Anoro Ellipta
Non-Proprietary Name:
Umeclidinium Bromide And Vilanterol Trifenatate
Substance Name:
Umeclidinium Bromide; Vilanterol Trifenatate
Usage Information:
This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems.
11-Digit NDC Billing Format:
00173086906
NDC to RxNorm Crosswalk:
  • RxCUI: 1487519 - umeclidinium/vilanterol 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters
  • RxCUI: 1487519 - 7 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
  • RxCUI: 1487519 - umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT 7 ACTUAT Dry Powder Inhaler
  • RxCUI: 1487524 - ANORO Ellipta 62.5/25 MCG/INHAL Dry Powder Inhaler, 7 Blisters
  • RxCUI: 1487524 - 7 ACTUAT umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Anoro]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Glaxosmithkline Llc
    Dosage Form:
    Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
    Administration Route(s):
  • Respiratory (inhalation) - Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.
    • Active Ingredient(s):
  • UMECLIDINIUM BROMIDE 62.5 ug/1
  • VILANTEROL TRIFENATATE 25 ug/1
    • Pharmacologic Class(es):
  • Adrenergic beta2-Agonists - [MoA] (Mechanism of Action)
  • Anticholinergic - [EPC] (Established Pharmacologic Class)
  • Cholinergic Antagonists - [MoA] (Mechanism of Action)
  • beta2-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    NDA203975
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    01-31-2014
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    0173-0869-101 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER
    0173-0869-611 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 7 POWDER in 1 INHALER

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0173-0869-06?

    The NDC Packaged Code 0173-0869-06 is assigned to a package of 1 tray in 1 carton / 1 inhaler in 1 tray / 7 powder in 1 inhaler of Anoro Ellipta, a human prescription drug labeled by Glaxosmithkline Llc. The product's dosage form is powder and is administered via respiratory (inhalation) form.

    Is NDC 0173-0869 included in the NDC Directory?

    Yes, Anoro Ellipta with product code 0173-0869 is active and included in the NDC Directory. The product was first marketed by Glaxosmithkline Llc on January 31, 2014 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0173-0869-06?

    The 11-digit format is 00173086906. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20173-0869-065-4-200173-0869-06